AT256141T
N-pyrazole a 2a receptor agonists
Abstract
Has the general formula (1) structure of the 2-n-pyrazole compounds of adenosine, and used for the purpose of treatment and cardiac imaging using compounds as A2A receptor agonists stimulate this invention of coronary vasodilation in mammals.
Term
Term ended
Expired 21 June 2020, 6.3 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
62 members in 27 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 33818599 | United States of America | A | |
| 0040281 | United States of America | W |
Members62
| Document | Office | Kind | |
|---|---|---|---|
| CA2377746A1 | Canada | A1 | |
| WO0078779A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7132400A | Australia | A | |
| WO0078779A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO20016350D0 | Norway | D0 | |
| NO20016350L | Norway | L | |
| EP1189916A2 | European Patent Office (EPO) | A2 | |
| KR20020028910A | Republic of Korea | A | |
| US6403567B1 | United States of America | B1 | |
| MXPA01013325A | Mexico | A | |
| CN1358191A | China | A | |
| IL147198D0 | Israel | D0 | |
| TR200200588T2 | Türkiye | T2 | |
| AR024441A1 | Argentina | A1 | |
| HK1044952A1 | Hong Kong, China | A1 | |
| JP2003506461A | Japan | A | |
| AU760806B2 | Australia | B2 | |
| US6642210B1 | United States of America | B1 | |
| ZA200200301B | South Africa | B | |
| EP1189916B1 | European Patent Office (EPO) | B1 | |
| AT256141TThis record | Austria | T | |
| ATE256141T1 | Austria | T1 | |
| DE60007127D1 | Germany | D1 | |
| BR0011856A | Brazil | A | |
| US2004038928A1 | United States of America | A1 | |
| DK1189916T3 | Denmark | T3 | |
| PT1189916E | Portugal | E | |
| NZ516334A | New Zealand | A | |
| ES2209974T3 | Spain | T3 | |
| DE60007127T2 | Germany | T2 | |
| CN1167709C | China | C | |
| KR100463300B1 | Republic of Korea | B1 | |
| HK1044952B | Hong Kong, China | B | |
| TWI230161B | Taiwan Province of China | B | |
| US2006052332A1 | United States of America | A1 | |
| IL147198A | Israel | A | |
| NO322457B1 | Norway | B1 | |
| US7144872B2 | United States of America | B2 | |
| US7183264B2 | United States of America | B2 | |
| CA2377746C | Canada | C | |
| US2007203090A1 | United States of America | A1 | |
| US7655637B2 | United States of America | B2 | |
| US2010160620A1 | United States of America | A1 | |
| NO2011002I1 | Norway | I1 | |
| FR11C0004I1 | France | I1 | |
| LU91785I2 | Luxembourg | I2 | |
| DE122011000010I1 | Germany | I1 | |
| US2011144320A1 | United States of America | A1 | |
| JP4727880B2 | Japan | B2 | |
| CY2011002I1 | Cyprus | I1 | |
| CY2011002I2 | Cyprus | I2 | |
| FR11C0004I2 | France | I2 | |
| US8278435B2 | United States of America | B2 | |
| NO2011002I2 | Norway | I2 | |
| US2013058866A1 | United States of America | A1 | |
| US8569260B2 | United States of America | B2 | |
| US2014073596A1 | United States of America | A1 | |
| BR0011856B1 | Brazil | B1 | |
| US9045519B2 | United States of America | B2 | |
| USRE47351E | United States of America | E | |
| BE2011C004I2 | Belgium | I2 | |
| BRPI0011856B8 | Brazil | B8 |
Numbers
- Application
- 960112
Titles2
- German
- N-PYRAZOL A2A REZEPTOR AGONISTEN
- English
- N-PYRAZOL A2A RECEPTOR AGONISTS
Classification
- CPC, 9
- C07H19/16
- A61P7/00
- C07D473/34
- A61P7/02
- A61P9/00
- A61P9/08
- A61P9/10
- A61P29/00
- A61P43/00
- IPC, 9
- C07H19 167
- A61K31 7076
- A61P7 00
- A61P7 02
- A61P9 00
- A61P9 10
- A61P29 00
- A61P43 00
- C07H19 16